tiprankstipranks
Trending News
More News >
B.R.A.I.N. Biotechnology Research and Information Network AG (GB:0RFI)
LSE:0RFI
UK Market
Advertisement

B.R.A.I.N. Biotechnology Research and Information Network (0RFI) Share Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

0RFI Financial Forecast

0RFI Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

0RFI Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on GB:0RFI
Kepler Capital
Kepler Capital
€5.8
Buy
155.51%
Upside
Reiterated
05/28/25
B.R.A.I.N. Biotechnology Research and Information Network (0RFI) Receives a Buy from Kepler Capital
Deutsche Bank  Analyst forecast on GB:0RFI
Deutsche Bank
Deutsche Bank
€10€8
Buy
252.42%
Upside
Reiterated
05/06/25
BRAIN Biotechnology Research (BNN:GR) PT Lowered to EUR8 at Deutsche BankDeutsche Bank analyst Jan Koch lowered the price target on BRAIN Biotechnology Research (BNN:GR) to EUR8.00 (from EUR10.00) while maintaining a Buy rating.
Warburg Research Analyst forecast on GB:0RFI
Warburg Research
Warburg Research
€5.9
Buy
159.91%
Upside
Reiterated
11/11/24
B.R.A.I.N. Biotechnology's Strategic CRISPR Rights Transfer to Akribion Enhances Cost Efficiency and Positive Outlook
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on GB:0RFI
Kepler Capital
Kepler Capital
€5.8
Buy
155.51%
Upside
Reiterated
05/28/25
B.R.A.I.N. Biotechnology Research and Information Network (0RFI) Receives a Buy from Kepler Capital
Deutsche Bank  Analyst forecast on GB:0RFI
Deutsche Bank
Deutsche Bank
€10€8
Buy
252.42%
Upside
Reiterated
05/06/25
BRAIN Biotechnology Research (BNN:GR) PT Lowered to EUR8 at Deutsche BankDeutsche Bank analyst Jan Koch lowered the price target on BRAIN Biotechnology Research (BNN:GR) to EUR8.00 (from EUR10.00) while maintaining a Buy rating.
Warburg Research Analyst forecast on GB:0RFI
Warburg Research
Warburg Research
€5.9
Buy
159.91%
Upside
Reiterated
11/11/24
B.R.A.I.N. Biotechnology's Strategic CRISPR Rights Transfer to Akribion Enhances Cost Efficiency and Positive Outlook
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering B.R.A.I.N. Biotechnology Research and Information Network

1 Month
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
+0.24%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of +0.24% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
+18.06%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of +18.06% per trade.
1 Year
Nicolas PauillacKepler Capital
Success Rate
2/5 ratings generated profit
20%
Average Return
-1.44%
reiterated a buy rating 3 months ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -1.44% per trade.
2 Years
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
-8.92%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -8.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0RFI Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
2
3
2
2
0
Buy
0
0
0
0
0
Hold
2
2
4
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
6
6
5
In the current month, 0RFI has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 0RFI average Analyst price target in the past 3 months is 2.00.
Each month's total comprises the sum of three months' worth of ratings.

0RFI Stock Forecast FAQ

What is GB:0RFI’s average 12-month price target, according to analysts?
Based on analyst ratings, B.R.A.I.N. Biotechnology Research and Information Network AG’s 12-month average price target is 2.00.
    What is GB:0RFI’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GB:0RFI, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is B.R.A.I.N. Biotechnology Research and Information Network AG a Buy, Sell or Hold?
        B.R.A.I.N. Biotechnology Research and Information Network AG has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is B.R.A.I.N. Biotechnology Research and Information Network AG’s share price target?
          The average share price target for B.R.A.I.N. Biotechnology Research and Information Network AG is 2.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €2.00 ,and the lowest forecast is €2.00. The average share price target represents -11.89% Decrease from the current price of €2.27.
            What do analysts say about B.R.A.I.N. Biotechnology Research and Information Network AG?
            B.R.A.I.N. Biotechnology Research and Information Network AG’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of B.R.A.I.N. Biotechnology Research and Information Network AG?
              To buy shares of GB:0RFI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis